Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -3.91% is 42% above its 5-year average of -6.73%, around the middle of its 5-year range (-25.60%–17.81%).
132.90% below its 12-month average of 11.88%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
-3.91%
RETURN ON ASSETS (ROA) AVG TTM
11.88%
RETURN ON ASSETS (ROA) AVG 3Y
0.12%
RETURN ON ASSETS (ROA) AVG 5Y
-6.73%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-132.90%
CURRENT VS 3Y AVG
-3228.00%
CURRENT VS 5Y AVG
+41.87%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
5.14%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-176.07%
vs the sector median at left
Hims & Hers Health, Inc.
Market Cap
$6.28B
Return on Assets (ROA)
-3.91%
TTM Avg
11.88%
3Y Avg
0.12%
5Y Avg
-6.73%
Market Cap
$6.78B
Return on Assets (ROA)
17.41%
TTM Avg
17.14%
3Y Avg
16.98%
5Y Avg
18.36%
Market Cap
$6.88B
Return on Assets (ROA)
-78.04%
TTM Avg
-72.67%
3Y Avg
-59.05%
5Y Avg
-50.29%
Market Cap
$5.22B
Return on Assets (ROA)
5.08%
TTM Avg
4.88%
3Y Avg
4.58%
5Y Avg
3.44%
Market Cap
$4.57B
Return on Assets (ROA)
15.41%
TTM Avg
17.55%
3Y Avg
14.67%
5Y Avg
15.71%
Market Cap
$8.56B
Return on Assets (ROA)
4.91%
TTM Avg
-3.24%
3Y Avg
-6.85%
5Y Avg
-10.42%
Market Cap
$3.05B
Return on Assets (ROA)
10.36%
TTM Avg
11.11%
3Y Avg
1.40%
5Y Avg
-7.68%
Market Cap
$9.85B
Return on Assets (ROA)
11.86%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$9.94B
Return on Assets (ROA)
6.59%
TTM Avg
6.34%
3Y Avg
6.05%
5Y Avg
6.29%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.28B | -3.91% | 11.88% | 0.12% | -6.73% |
| Chemed Corporation (CHE)vs › | $6.78B | 17.41% | 17.14% | 16.98% | 18.36% |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.88B | -78.04% | -72.67% | -59.05% | -50.29% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 5.08% | 4.88% | 4.58% | 3.44% |
| Doximity, Inc. (DOCS)vs › | $4.57B | 15.41% | 17.55% | 14.67% | 15.71% |
| Oscar Health, Inc. (OSCR)vs › | $8.56B | 4.91% | -3.24% | -6.85% | -10.42% |
| TransMedics Group, Inc. (TMDX)vs › | $3.05B | 10.36% | 11.11% | 1.40% | -7.68% |
| Insulet Corp. (PODD)vs › | $9.85B | 11.86% | 10.65% | 7.37% | 5.11% |
| The Ensign Group, Inc. (ENSG)vs › | $9.94B | 6.59% | 6.34% | 6.05% | 6.29% |
| Globus Medical, Inc. (GMED)vs › | $10.12B | 9.76% | 6.05% | 5.92% | 6.23% |
ROA
-3.9%
ROE
-43.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | 5.96% |
| 2024-12-31 | 17.81% |
| 2023-12-31 | -5.34% |
| 2022-12-31 | -17.93% |
| 2021-12-31 | -25.60% |
| 2020-12-31 | -15.26% |
| 2019-12-31 | -99.99% |
